NEW ISSUE
Infective Endocarditis & TAVI; Cerebral Protection Devices; IVUS Assessment in ViV-TAVI, Mini Focus on Antithrombotic Therapy …
February 19, 2021
Showing 1-4 of 4 articles
Interventions for hypertension
Prioritized Endpoints for Device-Based Hypertension Trials: the Win Ratio Methodology November 24, 2020 | 10.4244/EIJ-D-20-01090
Coronary interventions
Drug-Coated Stents Versus Bare-Metal Stents in Academic Research Consortium-Defined High Bleeding Risk Patients August 25, 2020 | 10.4244/EIJ-D-20-00749
Two-year outcomes of high bleeding risk patients with acute coronary syndrome after Biolimus A9 polymer-free drug-coated stents: a LEADERS FREE substudy
March 20, 2018 | 10.4244/EIJ-D-17-00720
Coronary interventions
Design and rationale for a randomised comparison of everolimus-eluting stents and coronary artery bypass graft surgery in selected patients with left main coronary artery disease: the EXCEL trial September 18, 2016 | 10.4244/EIJV12I7A141